Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pharmaids Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaids Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pharmaids Pharmaceuticals's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Pharmaids Pharmaceuticals's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaids Pharmaceuticals (BOM:524572) has a FCF Margin % of 0.00% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pharmaids Pharmaceuticals and its competitors. According to the industry distribution chart, Pharmaids Pharmaceuticals ranks #828 out of 959 companies in the Drug Manufacturers industry, placing it in the top 86.3%.
Is Pharmaids Pharmaceuticals' FCF Margin % too high?
Pharmaids Pharmaceuticals' current FCF Margin % is 0.00%. Based on the distribution chart, Pharmaids Pharmaceuticals ranks #828 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Pharmaids Pharmaceuticals has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Pharmaids Pharmaceuticals' FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Pharmaids Pharmaceuticals ranks #828 out of 959 companies for FCF Margin %. This places Pharmaids Pharmaceuticals in the lower half of its industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pharmaids Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaids Pharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaids Pharmaceuticals stock overvalued right now?
Pharmaids Pharmaceuticals (BOM:524572) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Pharmaids Pharmaceuticals' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Pharmaids Pharmaceuticals (BOM:524572), the current FCF Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pharmaids Pharmaceuticals Ltd is an Indian pharmaceutical company that manufactures specialty chemicals, skin care products, hospital care products, and generic drugs. Its product range includes vitamins and related compounds, hand sanitizers, antiseptic solutions, ointments, and various bulk drugs. The company operates from Hyderabad, India, serving domestic and select international markets. Pharmaids generates revenue prominently from the sale of these pharmaceutical and healthcare products. Its operations focus on manufacturing and supplying formulations across healthcare and personal care segments.
23GF Score
Get the complete analysis for BOM:524572
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524572 has been successfully added to your 
